CClinicalTrials.gg
CompletedNCT05155696Updated Sep 28, 2023

Probiotic Supplementation in Children With ADHD

An interventional study of Experimental: Kefir probiotic drink (supplied by Nourish) and Placebo comparator in ADHD, sponsored by St. Mary's University, Twickenham. Completed at 1 site in United Kingdom. Open to participants aged 8 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-28.

Sponsored by St. Mary's University, Twickenham · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
81
Allocation
Randomized
Ages
8 Years to 13 Years
Sex
All
01

Study summary

This randomised, placebo controlled trial explores the effects of supplementation with a probiotic drink (kefir) in children diagnosed with ADHD on behaviour, sleep, attention and the gut microbiome.

Read the detailed description

Children with Attention Deficit Hyperactivity Disorder (ADHD) can suffer debilitating symptoms, including problematic behaviour and sleep. Dietary manipulations may be a helpful treatment option for children, but the most effective are highly restrictive, with little known about why they might work.

Optimising gut bacteria may help alleviate some of the symptoms of this condition via the gut-brain-axis. The consumption of a probiotic fermented drink (kefir) can positively influence composition of gut bacteria.

The purpose of this study is to explore the effects of supplementation of a probiotic drink (kefir) on behaviour, sleep, attention and the gut microbiome in children diagnosed with ADHD.

In a six-week randomised controlled double-blind, placebo controlled trial, 70 children diagnosed with ADHD (aged 8-13 years) will be randomised to be given either a probiotic drink (kefir) or a placebo drink. At the beginning and the end of the study a combination of questionnaires, cognitive assessment, sleep/physical activity measures and microbiome analysis will be employed to assess the effect of kefir consumption on symptoms of ADHD and the gut microbiome.

02

Conditions studied

  • ADHD

Keywords

  • microbiome
  • ADHD
  • probiotic
  • Kefir
03

In context

Attention Deficit Disorder with Hyperactivity

1,514 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 255 are open to participants now.

This study's enrollment of 81 is above the median of 72 across 1,207 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

St. Mary's University, Twickenham is the lead sponsor of 16 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • A previous diagnosis of ADHD according to the DSM-IV or DSM-V criteria by a qualified health care professional.
  • Children aged between 8 and 13 years at the time of study.
  • Children with a comorbidity will be accepted.
  • Both males and females

Exclusion criteria

Exclusion Criteria:

  • Children currently undergoing a current course of behavioural therapy.
  • Children with a reported milk allergy or lactose intolerance.
  • Reported use of antibiotics, probiotics, antifungals or steroids in the past four weeks.
  • Diagnosis of a gastrointestinal disorder e.g., Inflammatory Bowel Disease or Coeliac disease.
  • Diagnosis of an auto-immune disease or compromised immunity.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
81 participants (actual)

Study arms

  • Experimental
    Kefir probiotic drink

    Daily kefir for 6 weeks.

    Dietary Supplement: Experimental: Kefir probiotic drink (supplied by Nourish)

  • Placebo comparator
    placebo comparator

    Daily non-fermented dairy based equivalent drink for 6 weeks.

    Dietary Supplement: Placebo comparator

Interventions

  • Dietary supplementExperimental: Kefir probiotic drink (supplied by Nourish)

    125ml per day of dairy based probiotic drink (Kefir) containing ≥ 50billion colony forming units (CFU), supplied in plain packaging.

  • Dietary supplementPlacebo comparator

    125ml of non-fermented dairy based placebo (UHT milk) per day, supplied in plain packaging.

06

What researchers measure

Primary outcomes

  1. Change in The Strengths and Weakness of ADHD-symptoms and Normal-behaviour (SWAN) scale

    18 item scale comparing the child to other children of the same age. Each item is responded to on a seven-point scale ranging from far below average (-3) to far above average (+3). The scores are summed and divided by the number of items, to express the summary score as the average rating-per-item (range -3 to +3, with lower scores indicating more severe ADHD symptoms).

    Time frame: week 0 and week 6

Secondary outcomes

  1. Change in The Go/NoGo test

    Participants respond to a particular stimulus while various stimuli are presented on a computer screen. There are 1500 milliseconds between each response, with 320 repetitions. Go errors (errors of omission) - A higher score = greater inattention (worse) NoGo errors (errors of commission) - A higher score = greater impulsivity (worse) Go reaction times - A higher score = less impulsivity (better) Go reaction time variability - A higher score = greater inattention (worse)

    Time frame: week 0 and week 6

  2. Change in mean activity during sleep.

    Actigraphy recordings. Range 0-∞. A higher score = less sound sleep (worse).

    Time frame: week 0 and week 6

  3. Change in minutes spent awake during the down period

    Actigraphy recordings. Range 0-∞. A higher score = less sound sleep (worse).

    Time frame: week 0 and week 6

  4. Change in sleep latency

    Actigraphy recordings of time taken to fall asleep. Range 0-∞. A higher score = more time taken to fall asleep (worse).

    Time frame: week 0 and week 6

  5. Change in sleep efficiency

    Actigraphy recordings of % down period spent asleep, after removing sleep latency. A higher score = better.

    Time frame: week 0 and week 6

  6. Change in wake after sleep onset

    Actigraphy recordings of minutes spent awake during the down period after removing sleep latency. Range 0-∞. A higher score = less sound sleep (worse).

    Time frame: week 0 and week 6

  7. Change in sleep fragmentation

    Actigraphy recordings of the number of awakenings/ total minutes of sleep x 100) - Higher score = more fragmented sleep (worse).

    Time frame: week 0 and week 6

  8. Change in mean daytime activity

    Actigraphy recording of mean daytime activity. (0-∞) not necessarily worse or better.

    Time frame: week 0 and week 6

  9. The Consensus Sleep diary

    Record of sleep - used qualitatively to detect and remove artefacts from the data. Takes approximately 3 minutes per day to complete.

    Time frame: week 0 and week 6

  10. The Consensus Sleep diary

    Record of sleep - used qualitatively to detect and remove artefacts from the data. Takes approximately 3 minutes per day to complete.

    Time frame: week 6

  11. Change in The Child's Sleep habits questionnaire

    Consists of 33 items. Each item is rated by parents using a three-point scale (with some items reverse-scored): 3 - Usually =occurs 5+ times a week 2 - Sometimes = occurs 2-4 times a week 1 - Rarely = occurs 0-1 times a week A Total Sleep Disturbances score is calculated as the sum of all scored questions. Total scores range from 33 to 99 - higher scores indicate more problematic sleep.

    Time frame: week 0 and week 6

  12. Change in Sleep self report

    Consists of 26 items. Each item is rated by children using a three-point scale (with some items reverse-scored): 3 - Usually = occurs 5+ times a week 2 - Sometimes = occurs 2-4 times a week 1 - Rarely = occurs 0-1 times a week. A Total Sleep Disturbances score is calculated as the sum of all scored questions. Total scores range from 26 to 78 - higher scores indicate more problematic sleep.

    Time frame: week 0 and week 6

  13. Change in The Gastrointestinal Severity Index

    A three-point rating scale across six gastrointestinal symptoms. A higher scores indicate worse symptoms. Total scores range from 0-12 - higher scores indicating more severe symptoms.

    Time frame: week 0 and week 6

  14. Change in stool microbiome analysis

    Investigate if there are changes in diversity and species in week 6 relative to week 0.

    Time frame: week 0 and week 6

07

Study locations

1 site
  • St Mary's University
    London, Greater London TW1 4SX, United Kingdom
08

References and documents

Individual participant data

Plan to share: Yes — anonymised data will be made available on an open access repository.

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05155696
Lead sponsor
St. Mary's University, Twickenham
Collaborators
Goldsmiths, University of London, London South Bank University
Responsible party
Kate (Senior Lecturer in Psychology, St. Mary's University, Twickenham) — Principal investigator
First posted
Dec 13, 2021
Start date
Jan 6, 2022
Primary completion
Sep 26, 2023
Completion
Sep 26, 2023
Last update
Sep 28, 2023

Study contacts

Kate Lawrence, PhD
principal investigator · St. Mary's University, Twickenham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion